Aug 17, 2026 07:54AM
Jul 30, 2026 06:30AM
Jul 21, 2026 07:00AM
Jul 21, 2026 07:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Jun 13, 2026 09:00AM Agios presents Phase 3 sickle cell disease trial results at EHA conference
Jun 13, 2026 09:00AM
Jun 1, 2026 05:00AM
Jun 1, 2026 05:00AM
May 29, 2026 07:00AM
May 29, 2026 07:00AM
May 22, 2026 09:15AM
May 22, 2026 09:15AM Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
May 12, 2026 09:32AM
May 12, 2026 09:31AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
Apr 29, 2026 06:30AM
Apr 21, 2026 06:41AM
Mar 31, 2026 01:08PM Leerink on Fulcrum Therapeutics (FULC): 'We believe this is a positive sign for FULC'
Mar 31, 2026 08:54AM
Mar 31, 2026 08:33AM
Mar 31, 2026 07:01AM
Mar 31, 2026 07:00AM
Mar 2, 2026 07:00AM
Feb 12, 2026 11:40AM
Feb 12, 2026 06:30AM Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Jan 12, 2026 07:03AM
Jan 12, 2026 07:00AM
Dec 26, 2025 07:01AM
Dec 24, 2025 12:28PM
Dec 23, 2025 07:45PM
Dec 23, 2025 07:45PM
Dec 9, 2025 06:56AM H.C. Wainwright Reiterates Buy Rating on Agios Pharma (AGIO)
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM
Nov 25, 2025 07:31AM
Nov 20, 2025 06:19AM
Nov 19, 2025 01:53PM
Nov 19, 2025 07:00AM
Nov 19, 2025 07:00AM Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease
Nov 3, 2025 09:01AM
Oct 30, 2025 06:30AM
Oct 17, 2025 08:01AM
Oct 17, 2025 08:00AM
Sep 5, 2025 06:44AM
Sep 5, 2025 05:02AM
Sep 4, 2025 12:08PM TD Cowen on Agios Pharma (AGIO): 'we view an extension rather than issuance of a CRL as a positive sign'
Sep 4, 2025 10:23AM

329,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All